E2104 Glucose monitor w cartridge

Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for E2104

DMEPOS fee schedule, July 2026 (DME26-C)

Payer policies and prior authorization for E2104

Payer coverage policies that name E2104

E2104 appears in 3 coverage policies from Aetna, Blue Cross & Blue Shield of Rhode Island.

PayerPolicyRole in policyReviewedDocument
AetnaDiabetes Tests, Programs and Supplies (0070)covered if criteria are metFeb 20, 2026payer document
Blue Cross & Blue Shield of Rhode IslandGlucose Monitoring Devices and Supplies
MEDICAL COVERAGE POLICY | 9
covered if criteria are metOct 1, 2026payer document
Blue Cross & Blue Shield of Rhode IslandGlucose Monitoring – Home - Non-OneTouch Brand
MEDICAL COVERAGE POLICY | 2
covered if criteria are metJan 22, 2025payer document

Medicaid fee-for-service

Prior authorization required or conditional in CO, IN, VA.

  • AZ: $53.39 (dme), effective Oct 1, 2026
  • CO: $35.09 (health_first_colorado), effective Jul 1, 2026
  • ND: $0.00 (dme), effective Aug 1, 2026
  • OH: $42.00 (dme), effective Apr 1, 2024
  • VA: $49.07 (dme), effective Dec 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.